To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Karl Swedberg - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Karl Swedberg

Senior Professor

Karl Swedberg
Senior Professor
karl.swedberg@gu.se

Room number: 1319
Postal Address: SU Sahlgrenska, 41345 Göteborg
Visiting Address: Wallenberglab/su , Göteborg


Institute of Medicine (More Information)
Box 428
405 30 Göteborg
www.medicine.gu.se
medicin@gu.se
Fax: +46 31823925
Visiting Address: Medicinaregatan 3, plan 5 , 413 90 Göteborg

About Karl Swedberg

Karl Swedberg, MD, PhD, FESC, is Senior Professor of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. He is a Scientific Advisor to the University of Gothenburg Centre for Person Centred Care (GPCC).

He was the first to report on survival benefits of a beta-blocker (1979), an ACE-inhibitor (1987), an angiotensinreceptor blocker (2003) and recently an ARNI (angiotensin receptor antagonist and neprilysin inhibitor 2014) in chronic heart failure. He has published widely in international journals with more than 600 publications in peer-reviewed journals, 340 original research papers and > 63000 citations.

He was Chairman of the Task Force on the Diagnosis and Treatment of Chronic Heart Failure that updated the ESC Guidelines 2005. He has participated in Steering Committees in numerous outcome trials in myocardial infarction and heart failure.

Rewards and distinctions

  • Recipient of the 2004 Kaufman Award of heart failure research from Cleveland Clinics, USA.
  • Awarded European Society of Cardiology (ESC) Gold medal 2007 for outstanding contributions to the cardiovascular field.
  • He gave the Paul Dudley White international lecture, AHA annual meeting in Orlando 2009.
  • "Lifetime Achievement Award" from Heart Failure Association (HFA) of ESC in 2016.
  • Member of the Editorial Board of several international journals.
  • 2005-2009 he served as Editor-in-Chief of the European Journal of Heart Failure.
  • He is Associate Editor in European Heart Journal since 2012.

Latest publications

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai et al.
Journal of the American College of Cardiology, Journal article 2019
Journal article

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, Michel Komajda, Karl Swedberg et al.
ESC heart failure, Journal article 2019
Journal article

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction PARADIGM-HF
S. Selvaraj, B. Claggett, A. Pozzi, J. J. V. McMurray, P. S. Jhund et al.
Circulation, Journal article 2019
Journal article

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
L. Shen, R. Rorth, D. Cosmi, S. L. Kristensen, M. C. Petrie et al.
European Journal of Heart Failure, Journal article 2019
Journal article

The Evolution of beta-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
P. Joseph, Karl Swedberg, D. P. Leong, S. Yusuf
Journal of the American College of Cardiology, Journal article 2019
Journal article

Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
J. Tromp, L. Shen, P. S. Jhund, I. S. Anand, P. E. Carson et al.
Journal of the American College of Cardiology, Journal article 2019
Journal article

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate
K. L. Chin, T. Collier, S. Pocock, B. Pitt, J. J. V. McMurray et al.
Clinical Research in Cardiology, Journal article 2019
Journal article

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Pooja Dewan, Pardeep S Jhund, Li Shen, Mark C Petrie, William T Abraham et al.
European journal of heart failure, Journal article 2019
Journal article

Showing 61 - 70 of 425

2017

The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF
U. M. Mogensen, L. Kober, S. L. Kristensen, P. S. Jhund, J. J. Gong et al.
American Heart Journal, Journal article 2017
Journal article

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial
T. Kitai, J. L. Grodin, R. J. Mentz, A. F. Hernandez, J. Butler et al.
European Journal of Heart Failure, Journal article 2017
Journal article

Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al
Karl Swedberg, M. Bohm, J. S. Borer, I. Ford, M. Komajda et al.
International Journal of Cardiology, Editorial letter 2017
Editorial letter

Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases
G. S. Filippatos, P. de Graeff, J. J. Bax, J. J. Borg, J. G. Cleland et al.
European Journal of Heart Failure, Journal article 2017
Journal article

Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
K. C. Bilchick, Y. F. Wang, A. Cheng, J. P. Curtis, K. Dharmarajan et al.
Journal of the American College of Cardiology, Journal article 2017
Journal article

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
A. H. Abdul-Rahim, A. C. Perez, R. L. MacIsaac, P. S. Jhund, B. L. Claggett et al.
European Heart Journal, Journal article 2017
Journal article

Showing 61 - 70 of 425

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?